Search Results
Results found for "preclinical pharmacology"
- Yao Lu (Jackie) | Dr. GPCR Ecosystem
Her work involves the pharmacological and structural characterisation of novel putative antipsychotic
- Dr. Oliver Hartley | Dr. GPCR Ecosystem
then Oliver has worked at the University of Geneva, where his research on peptide engineering and GPCR pharmacology
- Dr. Steven Foord | Dr. GPCR Ecosystem
Steven Foord Steve Foord trained as a Physiologist and Pharmacologist and worked for Glaxo through to He introduced molecular pharmacology to a wide range of the company's GPCR projects and was able to initiate
- Dr. Terry Hébert | Dr. GPCR Ecosystem
Terry Hébert is a Professor within the Department of Pharmacology & Therapeutics at McGill University
- Dr. Qing Fan | Dr. GPCR Ecosystem
Fan is currently an associate professor of Pharmacology and Pathology and Cell Biology at Columbia University
- Empowering Drug Discovery for the GPCR Community with Dr. Justin English | Dr. GPCR Ecosystem
His lab focuses on developing and innovating technologies to solve broad questions in pharmacology, with
- From Pipettes to Platforms The Evolution of GPCR Research | Dr. GPCR Ecosystem
Discover the evolution of GPCR research — from single pipettes to automated platforms shaping precision and insights: https://www.ecosystem.drgpcr.com/gpcr-university-pricing #GPCR #DrGPCR #DrugDiscovery #Pharmacology
- ep 175 with jens carlsson clip 1 | Dr. GPCR Ecosystem
This kind of predictive modeling challenges the traditional role of computation in pharmacology, where That scientific humility (combined with deep collaborations with medicinal chemists and pharmacologists This episode is essential listening for anyone thinking seriously about translational pharmacology and Yet, any pharmacologist who’s pushed beyond textbook theory knows: biology rarely plays fair. GPCR Podcast 4 days ago Molecular creativity in drug discovery Most pharmacologists are trained to chase
- G Proteins and GPCRs in Cancer: Novel Precision Targeted and Immunotherapies
Contest Committee Sponsors GPCR Retreat Program < Back to schedule G Proteins and GPCRs in Cancer: Novel Precision Gutkind is a Distinguished Professor and Chair of the Department of Pharmacology, School of Medicine, dysregulated signaling circuitries and individual genomic and molecular alterations to develop new precision
- Cannabinoid compounds to augment L-DOPA treatment in Parkinson's Disease
In April 2009, he joined the Department of Pharmacology and Toxicology at University of Toronto and has
- Dr. Jean-Philippe Pin | Dr. GPCR Ecosystem
using innovative approaches, including biosensors, cryo-EM, photoswitchable ligands, and nanobodies as pharmacological
- Dr. Maria Waldhoer | Dr. GPCR Ecosystem
She earned her M.Sc. in Zoology and Neurobiology before completing a Ph.D. in Biology and Pharmacology
- ep 175 with jens carlsson clip 2 | Dr. GPCR Ecosystem
They collaborate deeply with medicinal chemists, pharmacologists, and biotech partners to create workflows GPCR Podcast: model predict discover #DrGPCR #GPCR #CollaborationInScience #ComputationalChemistry #Pharmacology
- ep 175 with jens carlsson clip 3 | Dr. GPCR Ecosystem
screening compounds, or designing next-gen molecules, this insight reframes what “success” in computational pharmacology
- CRO Advisory | Dr. GPCR Ecosystem
Any CRO focused on GPCRs, pharmacology, discovery biology, or antibody discovery—regardless of size or Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution
- VC Insights | Dr. GPCR Ecosystem
and adapt quickly with contingency-ready paths " Yamina brings scientific clarity, leadership, and precision execution to complex pharmacological programs. Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution
- 🔥 New Course Alert! “Development of GPCR Ligands as Therapeutic Drugs” with Dr. Terry Kenakin is here! Spots are filling up fast—Premium Members get 25% off! This advanced course is exclusively available in the Ecosystem, so don’t miss your chance to learn from the best. 🔹 Secure your spot now! 👉 https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs #gpcr #drgpcr #pharmacolgy #drugdiscovery #research | Dr. GPCR Ecosystem
www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs #gpcr #drgpcr #pharmacolgy www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs #gpcr #drgpcr #pharmacolgy
- Dr. GPCR Board | Dr. GPCR Ecosystem
Maria Waldhoer "I am a pharmacologist with a ~30 years background in academia and industry, working both Trejo joined the faculty in the Department of Pharmacology at the University of North Carolina in 2000 and then moved to UC San Diego School Medicine, Department of Pharmacology in 2008, where she quickly In 2014, she was appointed Vice-Chair of the Department of Pharmacology. The long-term goal of Dr. The precise control of PAR signaling is critical for proper temporal and spatial dynamics of signaling
- Celtarys Research | Dr. GPCR Ecosystem
unparalleled scientific expertise ensure researchers can confidently advance their projects with greater precision in a competitive manner and in a short time (<3 months), customized fluorescent ligands with optimal pharmacological Chemistry and Technology from the University of Bari and completed her PhD in Biomolecular Sciences in Pharmacology live-cell imaging, empowering both academic and industrial scientists to uncover GPCR biology with greater precision Probes Innovative fluorescent probes that de-risk the pre-clinical drug discovery phase with optimal pharmacological
- 🚀 Ready to dive into the world of GPCR drug development? Join Dr. Terry Kenakin for the 4-week course “Development of GPCR Ligands as Therapeutic Drugs”! Get exclusive access to expert lectures, recordings, reading materials, and even a private call with Dr. Kenakin himself! Don’t miss this chance to level up your knowledge. 🔹 Spots are limited—save yours now! 👉 https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs #gpcr #drgpcr #pharmacolgy #drugdiscovery #research | Dr. GPCR Ecosystem
www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs #gpcr #drgpcr #pharmacolgy www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs #gpcr #drgpcr #pharmacolgy
- irreversible drugs post 2 | Dr. GPCR Ecosystem
www.ecosystem.drgpcr.com/post/beyond-clearance-the-strategic-power-of-irreversible-drug-binding #GPCR #DrGPCR #Pharmacology
- Dr. Antonella Di Pizio | Dr. GPCR Ecosystem
Join us to learn more about chemosensory GPCRs and how computational pharmacology can help better understand
- Dr. Kari Johnson | Dr. GPCR Ecosystem
Kari completed her Ph.D. in Pharmacology at Vanderbilt University before continuing her training as a
- Dr. Ross Cheloha | Dr. GPCR Ecosystem
Work in his independent laboratory is focused on developing new pharmacological tools via chemistry and
- Dr. Juan José Fung | Dr. GPCR Ecosystem
mainly focused on screening and assay development to bridge the gap between in vitro and in vivo GPCR pharmacology
- Dr. Daniel Isom | Dr. GPCR Ecosystem
Isom was recruited to the Molecular and Cellular Pharmacology Department at the University of Miami Miller School of Medicine in 2016, where he is currently a practicing molecular pharmacologist and biophysicist
- From Curiosity to Breakthrough: Ajay Yekkirala on GPCR Innovation | Dr. GPCR Ecosystem
Ajay Yekkirala is a GPCR pharmacologist, biotech entrepreneur, and co-founder of Superluminal Medicines strategic leaders seeking new drug development models Anyone curious about where AI meets molecular pharmacology Ajay Yekkirala is a molecular pharmacologist, biotech founder, and scientist whose career has been defined rejection letter pivoted him into a PhD program at the University of Iowa, where he studied opioid pharmacology machine learning to explore GPCR structure-function relationships and predict biased signaling with precision
- GPCR Courses | Dr. GPCR Ecosystem
GPCR Drug Discovery Gain insider methods from the pioneers shaping biased signaling, assay design, and pharmacology—skills Terry Kenakin Terry's Corner Author of 'A Pharmacology Primer', the definitive GPCR reference used by Pioneer in quantitative pharmacology methods. Dr. Yamina Berchiche Dr. enough depth to satisfy the hunger for theory while being full of practical knowledge Anonymous The best pharmacology Also super-valuable for those of us learning how to teach pharmacology Anonymous Dr.
- Dr. Paul Insel | Dr. GPCR Ecosystem
on, Paul was hooked and has since studied receptor function in human physiology, receptor molecular pharmacology
- Dr. Kathryn E Livingston | Dr. GPCR Ecosystem
Kathryn obtained her BS in Chemistry from Carnegie Mellon University and went on to receive a Ph.D. in Pharmacology





















